Phase I trial to determine the effects of food on an oral formulation of delafloxacin

Trial Profile

Phase I trial to determine the effects of food on an oral formulation of delafloxacin

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Sep 2014

At a glance

  • Drugs Delafloxacin (Primary)
  • Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Sponsors Melinta Therapeutics
  • Most Recent Events

    • 09 Sep 2014 Results presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy.
    • 16 May 2014 Status changed from planning to completed.
    • 14 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top